Form 4: Director Jasinski Acquires LMAT Shares Through Equity Vesting

Lemaitre Vascular Director Lawrence J. Jasinski acquired 10 shares of common stock through the vesting of restricted and performance stock units.

Summary

• Director Lawrence J. Jasinski acquired a total of 10 shares of Lemaitre Vascular Inc. common stock on December 12, 2025.
• These shares were acquired upon the release of dividend equivalent rights, which were connected to the vesting of a restricted stock unit (RSU) award and a performance stock unit (PSU) award.
• Both the RSU and PSU awards were originally granted on December 12, 2022.
• Each dividend equivalent right was the economic equivalent of one share of the Issuer's common stock, and the shares were acquired at an exercise price of $0.
• Following these transactions, Director Jasinski's direct beneficial ownership of common stock increased to 5,322 shares.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving the vesting of equity awards, which is a neutral event reflecting previously agreed-upon compensation.

Positives

• The acquisition of shares represents the routine fulfillment of previously granted equity compensation awards, indicating adherence to established compensation plans.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as this is a routine compensation event for a director.

Key Dates

Keywords

LEMAITRE VASCULAR, LMAT, Lawrence J Jasinski, Director, Insider Transaction, Form 4, Equity Vesting, Restricted Stock Units, Performance Stock Units, Dividend Equivalent Rights